Anesthesia for Suboccipital Craniotomy in a Patient with Lymphangioleiomyomatosis: A Case Report

by Robert A. Peterfreund, Emily Luman, Robert L. Martuza
Published 2012-01-01

Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma

by Dipongkor Saha, Samuel D Rabkin, Robert L Martuza
Published 2020-06-01

Replication-Competent Herpes Simplex Virus Vector G207 and Cisplatin Combination Therapy for Head and Neck Squamous Cell Carcinoma

by Ali Chahlavi, Tomoki Todo, Robert L. Martuza, Samuel D. Rabkin
Published 1999-06-01

In Situ Cancer Vaccination and Immunovirotherapy Using Oncolytic HSV

by Nusrat Jahan, Shanawaz M. Ghouse, Robert L. Martuza, Samuel D. Rabkin
Published 2021-08-01

Oncolytic herpes simplex virus expressing IL-2 controls glioblastoma growth and improves survival

by Howard L Kaufman, Dipongkor Saha, Samuel D Rabkin, Robert L Martuza, Praveen K Bommareddy, Hiroaki Wakimoto
Published 2024-04-01

Ionizing Radiation Does Not Alter the Antitumor Activity of Herpes Simplex Virus Vector G207 in Subcutaneous Tumor Models of Human and Murine Prostate Cancer

by Timothy J. Jorgensen, Sanford Katz, Ellen K. Wittmack, Susan Varghese, Tomoki Todo, Samuel D. Rabkin, Robert L. Martuza
Published 2001-01-01

Oncolytic Herpes Simplex Virus and PI3K Inhibitor BKM120 Synergize to Promote Killing of Prostate Cancer Stem-like Cells

by Lei Wang, Jianfang Ning, Hiroaki Wakimoto, Shulin Wu, Chin-lee Wu, Melissa R. Humphrey, Samuel D. Rabkin, Robert L. Martuza
Published 2019-06-01

Combination of Oncolytic Herpes Simplex Viruses Armed with Angiostatin and IL-12 Enhances Antitumor Efficacy in Human Glioblastoma Models

by Wei Zhang, Giulia Fulci, Hiroaki Wakimoto, Tooba A. Cheema, Jason S. Buhrman, Deva S. Jeyaretna, Anat O. Stemmer Rachamimov, Samuel D. Rabkin, Robert L. Martuza
Published 2013-06-01

Histone deacetylase inhibitors enhance oncolytic herpes simplex virus therapy for malignant meningioma

by Yoichiro Kawamura, Lingyang Hua, Alessandra Gurtner, Ego Wong, Juri Kiyokawa, Nadia Shah, Joshua Gorham, Hiroko Wakimoto, Samuel D. Rabkin, Robert L. Martuza, Hiroaki Wakimoto
Published 2022-11-01

Myc targeted CDK18 promotes ATR and homologous recombination to mediate PARP inhibitor resistance in glioblastoma

by Jian-Fang Ning, Monica Stanciu, Melissa R. Humphrey, Joshua Gorham, Hiroko Wakimoto, Reiko Nishihara, Jacqueline Lees, Lee Zou, Robert L. Martuza, Hiroaki Wakimoto, Samuel D. Rabkin
Published 2019-07-01

Characterization and oncolytic virus targeting of FAP-expressing tumor-associated pericytes in glioblastoma

by Ming Li, Guoping Li, Juri Kiyokawa, Zain Tirmizi, Leland G. Richardson, Jianfang Ning, Saumya Das, Robert L. Martuza, Anat Stemmer-Rachamimov, Samuel D. Rabkin, Hiroaki Wakimoto
Published 2020-12-01

An Aberrant Transcription Factor Network Essential for Wnt Signaling and Stem Cell Maintenance in Glioblastoma

by Esther Rheinbay, Mario L. Suvà, Shawn M. Gillespie, Hiroaki Wakimoto, Anoop P. Patel, Mohammad Shahid, Ozgur Oksuz, Samuel D. Rabkin, Robert L. Martuza, Miguel N. Rivera, David N. Louis, Simon Kasif, Andrew S. Chi, Bradley E. Bernstein
Published 2013-05-01

Curing glioblastoma: oncolytic HSV-IL12 and checkpoint blockade

by Saha, Dipongkor, Martuza, Robert L., Rabkin, Samuel D.
Published 2017

Anesthesia for Suboccipital Craniotomy in a Patient with Lymphangioleiomyomatosis: A Case Report

by Peterfreund, Robert Andrew, Luman, Emily, Martuza, Robert Lawrence
Published 2013

Combination of vinblastine and oncolytic herpes simplex virus vector expressing IL-12 therapy increases antitumor and antiangiogenic effects in prostate cancer models

by Passer, Brent J., Cheema, Tooba, Wu, Shulin, Wu, Chen-lee, Rabkin, Samuel D., Martuza, Robert L.
Published 2014

Flip-Flop HSV-BAC: Bacterial Artificial Chromosome Based System for Rapid Generation of Recombinant Herpes Simplex Virus Vectors Using Two Independent Site-specific Recombinases

by Kuroda, Toshihiko, Martuza, Robert Lawrence, Todo, Tomoki, Rabkin, Samuel David
Published 2011